Document Detail


Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR(mREN2)27 rats.
MedLine Citation:
PMID:  10373099     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
TGR(mREN2)27 (TGR) rats are transgenic animals with an additional mouse renin gene, which leads to overactivity of the renin-angiotensin system. Adult TGR rats are characterized by fulminant hypertension, hypertensive end-organ damage, and an inverse circadian blood pressure pattern. To study the ontogenetic development of cardiovascular circadian rhythms, telemetric blood pressure transmitters were implanted in male Sprague-Dawley (SPRD, n = 5) and heterozygous, transgenic TGR rats before 5 weeks of age. The TGR received either drinking water or enalapril 10 mg/L in drinking water (n = 5 per group). Drug intake was measured throughout the study by computerized monitoring of drinking volume. Circadian patterns in blood pressure and heart rate were analyzed from 5 to 11 weeks of age. In the first week after transmitter implantation, blood pressure did not differ among SPRD, untreated, and enalapril-treated TGR rats. In parallel with the rise in blood pressure of untreated TGR rats, a continuous delay of the circadian acrophase (time of fitted blood pressure maximum) was observed, leading to a complete reversal of the rhythm in blood pressure at an age of 8 weeks. Enalapril reduced blood pressure at night, but was less effective during the day, presumably due to the drinking pattern of the animals, which ingested about 90% of their daily water intake during the nocturnal activity period. After discontinuation of treatment, blood pressure returned almost immediately to values found in untreated TGR rats. In conclusion, the inverse circadian blood pressure profile in TGR rats develops in parallel with the increase in blood pressure. Direct effects of the brain renin-angiotensin system may be involved in the disturbed circadian rhythmicity in TGR(mREN2)27 rats.
Authors:
K Witte; B Lemmer
Related Documents :
3923959 - The influence of cyclo-oxygenase inhibitors on the cardiovascular effects of hydralazin...
2688409 - Hypertension as a disease of carbohydrate and lipoprotein metabolism.
10490899 - Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous me...
6875199 - The correlation between the development of sympathetic innervation and the development ...
2954429 - Intravenous administration of atriopeptin iii affects arterial blood pressure different...
25439399 - Impact of isoproterenol infusion on bis and metabolic values in pediatric patients unde...
8202419 - Renal adaptation to the failing heart. understanding the cascade of responses.
17641159 - Brief, large tidal volume ventilation initiates lung injury and a systemic response in ...
24805959 - Plasmin in urine from patients with type 2 diabetes and treatment-resistant hypertensio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chronobiology international     Volume:  16     ISSN:  0742-0528     ISO Abbreviation:  Chronobiol. Int.     Publication Date:  1999 May 
Date Detail:
Created Date:  1999-07-23     Completed Date:  1999-07-23     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  8501362     Medline TA:  Chronobiol Int     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  293-303     Citation Subset:  IM    
Affiliation:
Institute of Pharmacology and Toxicology, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Germany. witte@rumms.uni-mannheim.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Genetically Modified
Antihypertensive Agents / therapeutic use
Blood Pressure / drug effects,  genetics,  physiology*
Body Weight / drug effects
Circadian Rhythm*
Enalapril / therapeutic use
Heart Rate / drug effects
Heterozygote
Hypertension / drug therapy,  genetics,  physiopathology*
Male
Mice
Motor Activity
Rats
Rats, Sprague-Dawley
Renin / genetics*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 75847-73-3/Enalapril; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Food-entrained feeding and locomotor circadian rhythms in rats under different lighting conditions.
Next Document:  Urinary excretion of nitric oxide, cyclic GMP, and catecholamines during rest and activity period in...